| Income Statement | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenue earned | 347 | 246 | ||
| Cost of revenues | 585 | 538 | ||
| Gross profit | -238 | -292 | ||
| Impairment expenses on property, plant and equipment | 692 | - | ||
| Selling, general and administrative expenses including credit losses of 2,725 for the nine months ended september 30, 2024 and 0 for the three months ended september 30, 2024 and 24,367 for the nine months ended september 30, 2023 and 0 for the three months ended september 30, 2023 | 2,664 | 2,061 | ||
| Change in contingent consideration | 81 | 182 | ||
| Amortization of intangible assets | 196 | 226 | ||
| Cost of development services and research and development expenses | 4,523 | 1,489 | ||
| Operating income (loss) | -8,394 | -4,250 | ||
| Convertibleloansinducedconversionexpenses | - | -4,304 | ||
| Financial (expenses) income, net | -718 | -815 | ||
| Other income | -122 | 8 | ||
| Loss before income taxes | -9,234 | -9,361 | ||
| Tax expenses | 32 | 5 | ||
| Net loss | -9,266 | -9,366 | ||
| Net loss attributable to non-controlling interests (including redeemable) | -146 | -462 | ||
| Net income (loss) attributable to parent | -9,120 | -8,904 | ||
| Basic eps | 1.93 | 0.23 | ||
| Diluted eps | 1.93 | 0.23 | ||
| Basic average shares | 4,715,229 | 38,860,727 | ||
| Diluted average shares | 4,715,229 | 38,860,727 | ||
Orgenesis Inc. (ORGS)
Orgenesis Inc. (ORGS)